STOCK TITAN

CalciMedica: Stonepine reports 8.1% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CalciMedica, Inc. (CALC) common stock is the subject of an amended ownership report in which Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC and Jon M. Plexico each report shared beneficial ownership of 579,912 shares. The reported securities consist of 278,680 common shares and warrants to acquire 301,232 shares, subject to a 9.99% beneficial ownership limitation.

The reported 8.1% ownership is calculated using 6,895,149 shares of common stock outstanding as of November 5, 2026.

Reported beneficial ownership 579,912 shares Each of the four reporting persons reported this amount with shared voting and dispositive power.
Common shares held 278,680 shares Component of the securities reported as beneficially owned.
Shares warrants may acquire 301,232 shares Warrants are subject to a 9.99% beneficial ownership limitation.
Reported ownership percentage 8.1% Calculated using 6,895,149 shares outstanding as of November 5, 2026.
Common shares outstanding 6,895,149 shares As of November 5, 2026; used to calculate the reported ownership percentage.
Beneficial ownership limitation 9.99% Applies to the warrants to acquire 301,232 shares.
beneficial ownership limitation regulatory
"subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting power regulatory
"Shared Voting Power 579,912.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 579,912.00"
pecuniary interest financial
"except to the extent of that person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CALC shares does Stonepine report beneficially owning?

Each of the four reporting persons—Stonepine Capital Management, LLC; Stonepine Capital, L.P.; Stonepine GP, LLC; and Jon M. Plexico—reported beneficial ownership of 579,912 shares of CALC common stock. The reported securities comprise 278,680 common shares and warrants to acquire 301,232 shares.

What percentage of CALC does Stonepine report owning?

Each reporting person reported 8.1% beneficial ownership, calculated using 6,895,149 shares of CALC common stock outstanding as of November 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





38942Q202

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 278,680 shares of Common Stock, and (2) warrants to acquire 301,232 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 6,895,149 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 278,680 shares of Common Stock, and (2) warrants to acquire 301,232 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 6,895,149 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 278,680 shares of Common Stock, and (2) warrants to acquire 301,232 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 6,895,149 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The securities beneficially owned by the reporting persons consist of (1) 278,680 shares of Common Stock, and (2) warrants to acquire 301,232 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 6,895,149 shares of Common Stock outstanding as of November 5, 2026, as reported in the Form 10-Q filed by the Issuer on November 10, 2026.


SCHEDULE 13G



Stonepine Capital Management, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Stonepine Capital, L.P.
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:11/13/2026
Stonepine GP, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Jon M. Plexico
Signature:/s/ Jon M. Plexico
Name/Title:Reporting Person
Date:11/13/2026
Exhibit Information

AGREEMENT REGARDING JOINT FILING ON SCHEDULE 13G

Keep reading